Aristo Bio-Tech & Lifescience Ltd (ARISTO) is currently trading at 86.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Aristo Bio-Tech & Lifescience Limited is an Indian agrochemical manufacturer and contract manufacturer that formulates, packages and supplies pesticides — including insecticides, herbicides, fungicides and plant growth regulators — and provides toll manufacturing and job-work services to other crop protection companies, operating from a manufacturing and laboratory complex in Manjusar, Vadodara with distribution across several Indian states and export markets. The company reported total revenue of Rs. 25,653.93 lakh for the half year ended September 30, 2025, up about 19.7% versus the corresponding prior period, but profit before tax was Rs. 554.44 lakh with a visible compression in operating margin versus the prior half, signalling top-line growth accompanied by margin pressure. Balance sheet expanded materially: total assets rose to Rs. 25,011.32 lakh from Rs. 14,062.39 lakh at prior year-end, driven primarily by a sharp increase in trade receivables to Rs. 15,437.58 lakh and a rise in current liabilities, including short-term borrowings and trade payables, indicating higher scale but strained working capital dynamics. Cash generation remained positive with net cash from operations of Rs. 326.59 lakh in the half year, while investing outflow included purchases of fixed assets and net investing cash outflow of Rs. 173.94 lakh; the company modestly increased its cash balance to Rs. 208.15 lakh at period end versus Rs. 111.56 lakh previously. Aristo operates a diversified agrochemical product portfolio and provides contract manufacturing services, supported by an in-house laboratory and manufacturing set-up; results were taken on record after Audit Committee and Board review and have been subjected to a limited review by statutory auditors, with financials prepared under Indian Accounting Standards (AS) framework.

Over the past 52 weeks, Aristo Bio-Tech & Lifescience Ltd has traded between a low of ₹74.30 and a high of ₹135.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Aristo Bio-Tech & Lifescience Ltd has a market capitalization of approximately 58.55. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Aristo Bio-Tech & Lifescience Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 8.15 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 58.55 Cr, Aristo Bio-Tech & Lifescience Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Aristo Bio-Tech & Lifescience Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Aristo Bio-Tech & Lifescience Ltd is 8.15. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.